<code id='C96200B211'></code><style id='C96200B211'></style>
    • <acronym id='C96200B211'></acronym>
      <center id='C96200B211'><center id='C96200B211'><tfoot id='C96200B211'></tfoot></center><abbr id='C96200B211'><dir id='C96200B211'><tfoot id='C96200B211'></tfoot><noframes id='C96200B211'>

    • <optgroup id='C96200B211'><strike id='C96200B211'><sup id='C96200B211'></sup></strike><code id='C96200B211'></code></optgroup>
        1. <b id='C96200B211'><label id='C96200B211'><select id='C96200B211'><dt id='C96200B211'><span id='C96200B211'></span></dt></select></label></b><u id='C96200B211'></u>
          <i id='C96200B211'><strike id='C96200B211'><tt id='C96200B211'><pre id='C96200B211'></pre></tt></strike></i>

          fashion

          fashion

          author:Wikipedia    Page View:88
          Medicare is planning to send $9 billion in lump sum payments to more than 1,600 hospitals that participate in a drug discount program. Adobe

          WASHINGTON — Medicare is planning to send $9 billion in lump-sum payments to more than 1,600 hospitals that participate in a drug discount program after the Supreme Court found the program underpaid them for prescription drugs, the agency announced on Friday.

          To pay for the restitution, Medicare would slash all hospitals’ payments for other items and services by 0.5% for the next 16 years.

          advertisement

          The remedy accounts for four years of underpayments to hospitals that participate in the 340B drug discount program. The Trump administration dramatically reduced Medicare payments for discounted drugs in 2018, but the Supreme Court found they didn’t follow the proper procedure and that the payment scheme was illegal.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          What does generative AI mean for health care? We asked experts
          What does generative AI mean for health care? We asked experts

          MikeReddyforSTATHealthcarecompaniesareracingtoincorporategenerativeAItoolsintotheirproductpipelinesa

          read more
          Diabetes management: Digital health tools fall short, study says
          Diabetes management: Digital health tools fall short, study says

          AdobeThelastdecadehasseenbillionsofdollarsflowintodigitalhealthcompaniesthatpromisetoimproveoutcomes

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          Studies point to risks of excluding people with obesity from drug trials

          AdobePeoplewithobesityoftengounderrepresentedindrugdevelopmenttrials,acriticalgapthatresearcherssayl